Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

HCW Biologics Inc. (HCWB)

1.97   -0.005 (-0.25%) 05-16 01:16
Open: 2.08 Pre. Close: 1.975
High: 2.3899 Low: 1.9112
Volume: 49,376 Market Cap: 71(M)
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.39 - 2.41 2.41 - 2.42
Low: 1.88 - 1.9 1.9 - 1.91
Close: 1.95 - 1.97 1.97 - 1.99

Technical analysis

as of: 2022-05-13 4:38:43 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 3.15     One year: 3.73
Support: Support1: 1.89    Support2: 1.58
Resistance: Resistance1: 2.7    Resistance2: 3.2
Pivot: 2.2
Moving Average: MA(5): 2     MA(20): 2.31
MA(100): 2.33     MA(250): 0
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 11.1     %D(3): 8.5
RSI: RSI(14): 30.1
52-week: High: 7.05  Low: 1.88
Average Vol(K): 3-Month: 32 (K)  10-Days: 17 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ HCWB ] has closed above bottom band by 15.4%. Bollinger Bands are 15.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 15 May 2022
Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Decreases By 32.5% - Defense World

Mon, 09 May 2022
Insiders might want to re-evaluate their US$6.9m stock purchase as HCW Biologics Inc. (NASDAQ:HCWB) drops to US$74m - Simply Wall St

Tue, 19 Apr 2022
HCW Biologics' CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual ... - WDRB

Thu, 24 Mar 2022
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest - Yahoo Finance

Mon, 31 Jan 2022
Focused Wealth Management, Inc Buys PIMCO Active Bond ETF, iShares Core U.S. ... - Yahoo Finance

Thu, 20 Jan 2022
HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 36 (M)
Shares Float 12 (M)
% Held by Insiders 75.1 (%)
% Held by Institutions 0.5 (%)
Shares Short 91 (K)
Shares Short P.Month 94 (K)

Stock Financials

EPS -0.74
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.5
Profit Margin (%) -186.1
Operating Margin (%) -199.9
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0.11
Sales Per Share 0.11
EBITDA (p.s.) -0.22
Qtrly Earnings Growth 0
Operating Cash Flow -11 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -2.7
PEG Ratio 0
Price to Book value 1.3
Price to Sales 17.16
Price to Cash Flow -6.32

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.